Skip to main

Annual survey

We would appreciate it if you could complete our website survey, open until 28 November 2025.

Designation of Adalimumab (HUMIRA) as an Orphan Drug - AbbVie Pty Ltd

This item is authorised by the following title:

Latest version
C2012G0025514 November 2012

Legislation text